CTOs on the Move

New American Dimensions

www.nadllc.com

 
New American Dimensions is a Los Angeles, CA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nadllc.com
  • 6955 La Tijera Blvd Ste B
    Los Angeles, CA USA 90045
  • Phone: 310.670.6800

Executives

Name Title Contact Details

Similar Companies

Stick Enterprises Inc

Stick Enterprises Inc is a Woodland Hills, CA-based company in the Business Services sector.

Leckie and Associates

Leckie and Associates is a Lloydminster, AB-based company in the Business Services sector.

Denuo Source

Denuo Source is a Dallas, TX-based company in the Business Services sector.

Mojica R Lynn Dmd

Mojica R Lynn Dmd is a San Francisco, CA-based company in the Business Services sector.

Applied BioCode, Inc.

Applied BioCode focuses on research and development, manufacturing, and commercialization of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The HQ of the company is at Los Angles, California. The company develops, manufactures, and commercializes multiplex diagnostic testing products. Applied BioCode, Inc. has combined "digital barcodes" with immunochemistry and molecular probes to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The microscale BMB, with a diameter of human hair, is tagged with immunochemistry or molecular probes, allowing the digital barcode to be easily scanned and accurately identified for a very high number (4,096 barcodes) of biological targets with no ambiguity. Applied BioCode, Inc. products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. The company has currently received FDA Clearance for the BioCode® MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP). The Gastrointestinal Pathogen Panel (GPP) has also obtained the CE-Mark for use in European countries conforming to CE-Mark regulations. In the face of the COVID-19 pandemic, Applied BioCode, Inc. also manufactures a BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). Applied BioCode, Inc. also partners with a variety of diagnostic and pharmaceutical companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary diagnostics.